The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Parathyroid Neoplasms

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Parathyroid Neoplasms

 

High impact information on Parathyroid Neoplasms

 

Chemical compound and disease context of Parathyroid Neoplasms

 

Biological context of Parathyroid Neoplasms

 

Anatomical context of Parathyroid Neoplasms

 

Gene context of Parathyroid Neoplasms

 

Analytical, diagnostic and therapeutic context of Parathyroid Neoplasms

References

  1. Intrathyroidal parathyroid adenoma or hyperplasia. An occasionally overlooked cause of surgical failure in primary hyperparathyroidism. Spiegel, A.M., Marx, S.J., Doppman, J.L., Beazley, R.M., Ketcham, A.S., Kasten, B., Aurbach, G.D. JAMA (1975) [Pubmed]
  2. Medullary sponge kidney and renal-leak hypercalciuria. A link to the development of parathyroid adenoma? Dlabal, P.W., Jordan, R.M., Dorfman, S.G. JAMA (1979) [Pubmed]
  3. Cyclin D and oncogenesis. Motokura, T., Arnold, A. Curr. Opin. Genet. Dev. (1993) [Pubmed]
  4. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma. Warrell, R.P., Issacs, M., Alcock, N.W., Bockman, R.S. Ann. Intern. Med. (1987) [Pubmed]
  5. Transient neonatal hypocalcemia, hypomagnesemia, and high serum parathyroid hormone with maternal hyperparathyroidism. Monteleone, J.A., Lee, J.B., Tashjian, A.H., Cantor, H.E. Ann. Intern. Med. (1975) [Pubmed]
  6. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Carpten, J.D., Robbins, C.M., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-Wilson, J., Simonds, W.F., Gillanders, E.M., Kennedy, A.M., Chen, J.D., Agarwal, S.K., Sood, R., Jones, M.P., Moses, T.Y., Haven, C., Petillo, D., Leotlela, P.D., Harding, B., Cameron, D., Pannett, A.A., Höög, A., Heath, H., James-Newton, L.A., Robinson, B., Zarbo, R.J., Cavaco, B.M., Wassif, W., Perrier, N.D., Rosen, I.B., Kristoffersson, U., Turnpenny, P.D., Farnebo, L.O., Besser, G.M., Jackson, C.E., Morreau, H., Trent, J.M., Thakker, R.V., Marx, S.J., Teh, B.T., Larsson, C., Hobbs, M.R. Nat. Genet. (2002) [Pubmed]
  7. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. Cryns, V.L., Thor, A., Xu, H.J., Hu, S.X., Wierman, M.E., Vickery, A.L., Benedict, W.F., Arnold, A. N. Engl. J. Med. (1994) [Pubmed]
  8. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. Arnold, A., Staunton, C.E., Kim, H.G., Gaz, R.D., Kronenberg, H.M. N. Engl. J. Med. (1988) [Pubmed]
  9. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. Korkor, A.B. N. Engl. J. Med. (1987) [Pubmed]
  10. Multicellular origin of parathyroid "adenomas". Fialkow, P.J., Jackson, C.E., Block, M.A., Greenawald, K.A. N. Engl. J. Med. (1977) [Pubmed]
  11. Percutaneous ethanol injection of parathyroid adenomas in primary hyperparathyroidism. Verges, B., Cercueil, J.P., Pfitzenmeyer, P., Pascuad, F., Vaillant, G., Brun, J.M., Putelat, R. Lancet (1991) [Pubmed]
  12. Oxyphilic parathyroid adenoma and lithium therapy. de Celis, G., Fiter, M., Latorre, X., Llebaria, C. Lancet (1998) [Pubmed]
  13. Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. Sherwood, J.K., Ackroyd, F.W., Garcia, M. Lancet (1980) [Pubmed]
  14. Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma. Jüngst, D. Lancet (1984) [Pubmed]
  15. Uptake of Technetium pertechnetate in a parathyroid adenoma presenting as an Iodine-131 "cold" nodule. Alagumalai, K., Avramides, A., Carter, A.C., Solomon, N.A. Ann. Intern. Med. (1979) [Pubmed]
  16. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. Silverberg, S.J., Rubin, M.R., Faiman, C., Peacock, M., Shoback, D.M., Smallridge, R.C., Schwanauer, L.E., Olson, K.A., Klassen, P., Bilezikian, J.P. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  17. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Szabó, J., Heath, B., Hill, V.M., Jackson, C.E., Zarbo, R.J., Mallette, L.E., Chew, S.L., Besser, G.M., Thakker, R.V., Huff, V. Am. J. Hum. Genet. (1995) [Pubmed]
  18. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Hemmer, S., Wasenius, V.M., Haglund, C., Zhu, Y., Knuutila, S., Franssila, K., Joensuu, H. Am. J. Pathol. (2001) [Pubmed]
  19. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. Tahara, H., Smith, A.P., Gaz, R.D., Zariwala, M., Xiong, Y., Arnold, A. J. Bone Miner. Res. (1997) [Pubmed]
  20. Molecular pathogenesis of primary hyperparathyroidism. Arnold, A., Shattuck, T.M., Mallya, S.M., Krebs, L.J., Costa, J., Gallagher, J., Wild, Y., Saucier, K. J. Bone Miner. Res. (2002) [Pubmed]
  21. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Martin, P., Bergmann, P., Gillet, C., Fuss, M., Corvilain, J., Van Geertruyden, J. Arch. Intern. Med. (1990) [Pubmed]
  22. Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Hobbs, M.R., Pole, A.R., Pidwirny, G.N., Rosen, I.B., Zarbo, R.J., Coon, H., Heath, H., Leppert, M., Jackson, C.E. Am. J. Hum. Genet. (1999) [Pubmed]
  23. Severe neurological disease associated with hyperparathyroidism. Patten, B.M., Pages, M. Ann. Neurol. (1984) [Pubmed]
  24. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Haven, C.J., Howell, V.M., Eilers, P.H., Dunne, R., Takahashi, M., van Puijenbroek, M., Furge, K., Kievit, J., Tan, M.H., Fleuren, G.J., Robinson, B.G., Delbridge, L.W., Philips, J., Nelson, A.E., Krause, U., Dralle, H., Hoang-Vu, C., Gimm, O., Morreau, H., Marsh, D.J., Teh, B.T. Cancer Res. (2004) [Pubmed]
  25. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S., Itakura, M. Cancer Res. (1992) [Pubmed]
  26. Ectopic thyroid tissue on thallium/technetium parathyroid scan. Asp, A., Hasbargen, J., Blue, P., Kidd, G.S. Arch. Intern. Med. (1987) [Pubmed]
  27. Co-secretion of parathyroid hormone and parathyroid-hormone-related protein via a regulated pathway in human parathyroid adenoma cells. Matsushita, H., Usui, M., Hara, M., Shishiba, Y., Nakazawa, H., Honda, K., Torigoe, K., Kohno, K., Kurimoto, M. Am. J. Pathol. (1997) [Pubmed]
  28. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Rosenberg, C.L., Motokura, T., Kronenberg, H.M., Arnold, A. Oncogene (1993) [Pubmed]
  29. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. Haven, C.J., van Puijenbroek, M., Karperien, M., Fleuren, G.J., Morreau, H. J. Pathol. (2004) [Pubmed]
  30. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. Shattuck, T.M., Costa, J., Bernstein, M., Jensen, R.T., Chung, D.C., Arnold, A. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  31. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. Arnold, A., Kim, H.G., Gaz, R.D., Eddy, R.L., Fukushima, Y., Byers, M.G., Shows, T.B., Kronenberg, H.M. J. Clin. Invest. (1989) [Pubmed]
  32. Expression of platelet-derived growth factor beta-receptors on stromal tissue cells in human carcinoid tumors. Funa, K., Papanicolaou, V., Juhlin, C., Rastad, J., Akerström, G., Heldin, C.H., Oberg, K. Cancer Res. (1990) [Pubmed]
  33. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Martin, P., Bergmann, P., Gillet, C., Fuss, M., Kinnaert, P., Corvilain, J., van Geertruyden, J. Arch. Intern. Med. (1986) [Pubmed]
  34. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? Dotzenrath, C., Teh, B.T., Farnebo, F., Cupisti, K., Svensson, A., Toell, A., Goretzki, P., Larsson, C. J. Clin. Endocrinol. Metab. (1996) [Pubmed]
  35. A thymoma as a cause of true ectopic hyperparathyroidism. Rizzoli, R., Pache, J.C., Didierjean, L., Bürger, A., Bonjour, J.P. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
 
WikiGenes - Universities